INVESTOR RELATIONS

ANNUAL REPORT

FISCAL YEAR 2058 — A RECORD YEAR OF GROWTH, INNOVATION, AND SHAREHOLDER VALUE CREATION.

FROM THE CHAIRMAN AND CEO

LETTER TO SHAREHOLDERS

DEAR SHAREHOLDERS,

FISCAL YEAR 2058 WAS A TRANSFORMATIVE YEAR FOR WEYLAND-YUTANI CORPORATION. WE DELIVERED RECORD REVENUE OF $45.2 TRILLION, AN 8.3% INCREASE OVER THE PRIOR YEAR, WHILE EXPANDING NET INCOME MARGINS TO 26.8%. THESE RESULTS REFLECT THE STRENGTH OF OUR DIVERSIFIED BUSINESS MODEL AND THE EXCEPTIONAL EXECUTION OF OUR TEAMS ACROSS ALL SEVEN OPERATING DIVISIONS.

OUR TERRAFORMING OPERATIONS DIVISION ACHIEVED A SIGNIFICANT MILESTONE, SURPASSING $8 TRILLION IN ANNUAL REVENUE FOR THE FIRST TIME AS WE BROUGHT 47 NEW ATMOSPHERIC PROCESSING INSTALLATIONS ONLINE. THE CYBERNETICS DIVISION LAUNCHED THE DAVID-9 SERIES, OUR MOST ADVANCED SYNTHETIC PLATFORM TO DATE, TO STRONG COMMERCIAL AND INSTITUTIONAL DEMAND.

IN ENERGY SYSTEMS, OUR NEXT-GENERATION FUSION REACTOR ACHIEVED COMMERCIAL VIABILITY, OPENING A NEW REVENUE STREAM ESTIMATED AT $3 TRILLION ANNUALLY AT FULL DEPLOYMENT. HEALTH SCIENCES CONTINUED ITS RAPID GROWTH WITH THE MEDPOD 5000 RECEIVING REGULATORY APPROVAL IN 42 JURISDICTIONS, BRINGING OUR AUTONOMOUS SURGICAL TECHNOLOGY TO BILLIONS MORE PATIENTS.

WE ALSO MADE STRATEGIC INVESTMENTS IN OUR FUTURE, ALLOCATING $6.8 TRILLION TO RESEARCH AND DEVELOPMENT, REPRESENTING 15% OF REVENUE. THIS INVESTMENT SUPPORTS OVER 200 ACTIVE R&D PROGRAMS SPANNING FTL PROPULSION OPTIMIZATION, ADVANCED MATERIALS, SYNTHETIC COGNITION, AND NEXT-GENERATION ATMOSPHERIC PROCESSING TECHNOLOGY.

OUR COMMITMENT TO RESPONSIBLE OPERATIONS REMAINED STEADFAST. WE INVESTED $1.2 TRILLION IN SUSTAINABILITY INITIATIVES, EXPANDED THE EXPLORERS ACADEMY TO 250,000 STUDENTS, AND MAINTAINED OUR POSITION AS THE LEADING EMPLOYER OF MILITARY VETERANS WORLDWIDE.

LOOKING AHEAD, I AM CONFIDENT IN OUR STRATEGIC POSITION. THE DEMAND FOR TERRAFORMING, ENERGY, AND HEALTHCARE SERVICES CONTINUES TO ACCELERATE AS HUMANITY EXPANDS ACROSS THE STARS. WEYLAND-YUTANI IS UNIQUELY POSITIONED TO MEET THAT DEMAND.

ON BEHALF OF THE BOARD OF DIRECTORS AND OUR 527,000 EMPLOYEES, THANK YOU FOR YOUR CONTINUED TRUST AND INVESTMENT IN OUR COMPANY.

HIDEO YUTANI III
CHAIRMAN AND CHIEF EXECUTIVE OFFICER
FINANCIAL PERFORMANCE

KEY METRICS

METRIC
FY2058
FY2057
CHANGE
REVENUE
$45.2T
$41.7T
+8.3%
NET INCOME
$12.1T
$10.4T
+16.3%
EPS
$238.41
$204.88
+16.4%
FREE CASH FLOW
$9.8T
$8.3T
+18.1%
DIVIDENDS PAID
$6.9T
$6.2T
+11.3%
R&D SPEND
$6.8T
$5.9T
+15.3%
SEGMENT REPORTING

DIVISION PERFORMANCE

TERRAFORMING OPERATIONS

$8.2T
REVENUE • +11.4% YOY

47 NEW ATP INSTALLATIONS. 12 ATMOSPHERES DECLARED BREATHABLE. RECORD BACKLOG OF $24T IN CONTRACTED PROJECTS.

CYBERNETICS & SYNTHETICS

$7.1T
REVENUE • +9.2% YOY

DAVID-9 SERIES LAUNCH. 15,000 UNITS DELIVERED. AUTONOMOUS SYSTEMS DIVISION GREW 22% ON INDUSTRIAL DEMAND.

ENERGY SYSTEMS

$6.8T
REVENUE • +7.6% YOY

NEXT-GEN FUSION REACTOR COMMERCIALIZED. FTL DRIVE EFFICIENCY IMPROVED 12%. 30 NEW POWER INSTALLATIONS COMPLETED.

SECURITY SOLUTIONS

$6.4T
REVENUE • +5.8% YOY

EXPANDED GOVERNMENT CONTRACTS. NEW PERIMETER DEFENSE SYSTEMS FOR 85 COLONIES. CYBERSECURITY DIVISION GREW 18%.

HEALTH SCIENCES

$5.9T
REVENUE • +14.2% YOY

MEDPOD 5000 APPROVED IN 42 JURISDICTIONS. PHARMACEUTICAL DIVISION SECURED 12 NEW PATENTS. COLONY HEALTHCARE CONTRACTS EXPANDED.

ELECTRONICS & BIOLOGICAL SCIENCES

$10.8T
COMBINED REVENUE • +6.1% YOY

HOLOGRAPHIC SYSTEMS ADOPTED BY 200+ COMMERCIAL CLIENTS. BIOLOGICAL RESEARCH DELIVERED 8 NEW COMMERCIAL APPLICATIONS.

LOOKING AHEAD

STRATEGIC PRIORITIES

1. ACCELERATE TERRAFORMING CAPACITY

INCREASE ATMOSPHERIC PROCESSOR PRODUCTION BY 30% OVER THE NEXT THREE YEARS TO MEET SURGING DEMAND FROM THE COLONIAL ADMINISTRATION AND PRIVATE COLONIZATION ENTITIES. INVEST $4T IN NEW MANUFACTURING FACILITIES ON EARTH AND LUNA.

2. EXPAND HEALTH SCIENCES GLOBALLY

DEPLOY MEDPOD TECHNOLOGY TO ALL COLONY WORLDS AND EXPAND EARTH-SIDE DISTRIBUTION TO UNDERSERVED MARKETS. TARGET: 500,000 MEDPOD INSTALLATIONS BY FY2062, MAKING AUTONOMOUS SURGICAL CARE UNIVERSALLY ACCESSIBLE.

3. ADVANCE SYNTHETIC INTELLIGENCE

CONTINUE INVESTMENT IN THE DAVID SERIES PLATFORM WITH A FOCUS ON COGNITIVE ENHANCEMENT AND SPECIALIZED APPLICATIONS. EXPAND THE SYNTHETIC WORKFORCE TO SUPPORT HAZARDOUS OPERATIONS AND ACCELERATE COLONY DEVELOPMENT.

4. DISCIPLINED CAPITAL RETURN

MAINTAIN OUR COMMITMENT TO RETURNING CAPITAL TO SHAREHOLDERS THROUGH DIVIDENDS AND SHARE REPURCHASES. THE BOARD HAS AUTHORIZED A NEW $2T BUYBACK PROGRAM AND APPROVED A 10% INCREASE IN THE QUARTERLY DIVIDEND.

DISCLOSURE

RISK FACTORS

INVESTORS SHOULD CAREFULLY CONSIDER THE FOLLOWING RISK FACTORS, AMONG OTHERS, WHEN EVALUATING AN INVESTMENT IN WEYLAND-YUTANI CORPORATION SECURITIES:

MARKET AND ECONOMIC RISK: GLOBAL AND INTERSTELLAR ECONOMIC CONDITIONS MAY ADVERSELY AFFECT DEMAND FOR OUR PRODUCTS AND SERVICES. FLUCTUATIONS IN COMMODITY PRICES, CURRENCY EXCHANGE RATES, AND INTERSTELLAR TRADE POLICIES COULD IMPACT FINANCIAL RESULTS.
REGULATORY RISK: OUR OPERATIONS ARE SUBJECT TO EXTENSIVE REGULATION BY EARTH GOVERNMENTS, THE COLONIAL ADMINISTRATION, AND VARIOUS INTERNATIONAL BODIES. CHANGES IN REGULATION COULD INCREASE COMPLIANCE COSTS OR RESTRICT BUSINESS ACTIVITIES.
OPERATIONAL RISK: OFF-WORLD OPERATIONS INVOLVE INHERENT RISKS INCLUDING EQUIPMENT FAILURE, ENVIRONMENTAL HAZARDS, SUPPLY CHAIN DISRUPTION, AND PERSONNEL SAFETY CHALLENGES. CATASTROPHIC EVENTS COULD RESULT IN SIGNIFICANT FINANCIAL LOSSES.
TECHNOLOGY RISK: OUR COMPETITIVE POSITION DEPENDS ON CONTINUED INNOVATION. FAILURE TO DEVELOP NEW TECHNOLOGIES OR THE EMERGENCE OF DISRUPTIVE COMPETITORS COULD ADVERSELY AFFECT MARKET SHARE AND PROFITABILITY.
GEOPOLITICAL RISK: POLITICAL INSTABILITY ON EARTH OR IN COLONIAL TERRITORIES COULD DISRUPT OPERATIONS, DAMAGE ASSETS, OR RESTRICT MARKET ACCESS. INTERGOVERNMENTAL DISPUTES MAY AFFECT TRADE AND BUSINESS CONDITIONS.

THIS IS NOT AN EXHAUSTIVE LIST OF RISK FACTORS. PLEASE REFER TO OUR ANNUAL REPORT ON FORM 10-K FILED WITH THE SECURITIES AND EXCHANGE COMMISSION FOR A COMPLETE DISCUSSION OF RISKS AND UNCERTAINTIES.